<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-695X</journal-id>
<journal-title><![CDATA[Revista Clínica de Medicina de Familia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Clin Med Fam]]></abbrev-journal-title>
<issn>1699-695X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Medicina de Familia y Comunitaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-695X2019000200067</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Seguimiento a dos años de pacientes con diabetes mellitus tipo 2 atendidos en dos centros de salud, en España y Portugal]]></article-title>
<article-title xml:lang="en"><![CDATA[Two-year follow-up of type 2 diabetic patients seen in two health care centers in Spain and Portugal]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López García]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Briones Monteagudo]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reolid Martínez]]></surname>
<given-names><![CDATA[Ricardo E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores Copete]]></surname>
<given-names><![CDATA[María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mudarra Tercero]]></surname>
<given-names><![CDATA[Esther]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Campo Giménez]]></surname>
<given-names><![CDATA[María del]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Servicio de Salud de Castilla-La Mancha Gerencia de Atención Integrada de Albacete Centro de Salud Zona IV (Albacete)]]></institution>
<addr-line><![CDATA[Albacete ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Servicio de Salud de Castilla-La Mancha Gerencia de Atención Integrada de Albacete Centro de Salud La Roda (Albacete)]]></institution>
<addr-line><![CDATA[Albacete ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>12</volume>
<numero>2</numero>
<fpage>67</fpage>
<lpage>74</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-695X2019000200067&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-695X2019000200067&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-695X2019000200067&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Conocer los cambios en el grado de control después de 2 años, de pacientes con diabetes mellitus tipo 2 (DM2) en un centro de Salud español (público, SESCAM) y otro portugués (Unidad de Salud Funcional).  Diseño: Estudio de cohorte.  Emplazamiento: Atención Primaria.  Participantes: Pacientes con DM2 que revisados 2 años después de un primer control (julio y noviembre del 2014, respectivamente en Portugal y España).  Mediciones Principales: A partir de las historias clínicas informatizas se obtuvieron los siguientes datos: sexo, edad, años de evolución, índice de masa corporal (IMC), microalbuminuria, hemoglobina glicosilada (HbA1c), perfil lipídico, presencia de complicaciones y tratamiento. La información fue introducida en una base de datos informatizada por medio del programa estadístico SPSS 17.0. Se realizó estadística descriptiva y comparación de proporciones y medias/medianas.  Resultados: En 2014 se estudiaron 200 pacientes portugueses y 278 españoles. Dos años después, se disponía de información en sus historias clínicas para 135 portugueses y 248 españoles. La media de edad de estos pacientes en 2016 era de 71,2 años (DE: 11,0), con 46,0 % de mujeres. No había diferencias en la distribución por edad y sexo entre ambos centros. La mediana de variación en la HbA1c a los 2 años era 0,0 (rango intercuartil:-0,4 a 0,5), sin diferencias estadísticamente significativas en los portugueses y un moderado aumento (p=0,05) para los españoles. Los portugueses presentaban una disminución media del IMC de 0,05 (IC95 %:-0,27 a 0,37) y los españoles tenían un aumento medio de 0,07 (IC95 %:-0,27 a 0,41), sin existir diferencias estadísticamente significativas.  Conclusiones: A los 2 años de seguimiento, los pacientes portugueses mostraron una leve reducción de peso, con estabilidad en sus cifras de HbA1c, mientras que los españoles empeoraron ligeramente en ambos parámetros.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective: The aim of the study is to know the changes in the degree of control of patients with type 2 diabetes mellitus in a Spanish health center (public, SESCAM) and a Portuguese health center (Functional Health Unit) after a two-year follow-up period.  Design: Cohort study.  Location: Primary Care.  Participants: Patients with type 2 diabetes who were reviewed two years after a first control (July and November 2014, respectively in Portugal and Spain).  Main measurements: The data obtained from the computerized clinical records were sex, age, years of disease course, body mass index (BMI), microalbuminuria, glycosylated hemoglobin (HbA1c), lipid profile, complications, and treatment. The information was entered into a computerized database with the statistical program SPSS 17.0. Descriptive statistics and comparison of proportions and means/medians were performed.  Results: 200 Portuguese patients and 278 Spanish patients were studied in 2014. Information on their clinical follow-up was available two years after for 135 Portuguese and 248 Spanish. The mean age of these patients in 2016 was 71.2 years (SD: 11.0), with 46.0% of women. There were no differences in the distribution by age and sex in both centers. The median of variation in HbA1c after 2 years was 0.0 (interquartile range:-0.4 to 0.5), without statistically significant (NS) differences for Portuguese patients and moderate increase (p=0.05) for Spanish patients. The Portuguese presented a mean BMI decrease of 0.05 (95%CI:-0.27 to 0.37) and Spanish patients had a mean increase of 0.07 (95%CI:-0.27 to 0.41), NS differences.  Conclusion: After 2 years of follow-up, Portuguese patients showed a slight weight reduction, with stability in their HbA1c levels, while Spanish patients worsened slightly in both parameters.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes Mellitus tipo 2]]></kwd>
<kwd lng="es"><![CDATA[Atención Primaria de Salud]]></kwd>
<kwd lng="es"><![CDATA[Estudios de Seguimiento]]></kwd>
<kwd lng="en"><![CDATA[Diabetes Mellitus, Type 2]]></kwd>
<kwd lng="en"><![CDATA[Primary Health Care]]></kwd>
<kwd lng="en"><![CDATA[Follow-Up Studies]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Informe mundial sobre la diabetes. Resumen de orientación]]></source>
<year>2016</year>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín Zurro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atención Primaria y diabetes mellitus tipo 2: limitaciones actuales del cribado y las acciones comunitarias]]></article-title>
<source><![CDATA[Endocrinol Nutr]]></source>
<year>2009</year>
<volume>56</volume>
<page-range>51-2</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goday]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Cardorniga]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pablos]]></surname>
<given-names><![CDATA[P de]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de la Diabetes tipo 2 en España]]></article-title>
<source><![CDATA[Endocrinol Nutr]]></source>
<year>2002</year>
<volume>49</volume>
<page-range>113-26</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nathan]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Buse]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrannini]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Holman]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Sherwin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<collab>American Diabetes Association</collab>
<collab>European Association for Study of Diabetes</collab>
<article-title xml:lang=""><![CDATA[Medical Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and ajustement of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
<volume>32</volume>
<page-range>193-203</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Grunberger]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bode]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Handelsman]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[IB]]></given-names>
</name>
<name>
<surname><![CDATA[Jovanovic]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement]]></article-title>
<source><![CDATA[Endocr Pract]]></source>
<year>2016</year>
<volume>22</volume>
<page-range>231-61</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reolid Martínez]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Flores Copete]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar Rabadán]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes Corte-Real]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jesus Ramalho Proença]]></surname>
<given-names><![CDATA[VC de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conociendo las Unidades de Saúde Familiar: otro modelo de Medicina de Familia]]></article-title>
<source><![CDATA[Rev Clin Med Fam]]></source>
<year>2015</year>
<volume>8</volume>
<page-range>137-44</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2018</year>
<volume>41</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S73-85</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>Canadian Diabetes Association Clinical Practice Guidelines Expert Commitee</collab>
<article-title xml:lang=""><![CDATA[Pharmacologic Management of Type 2 Diabetes 2016. Interim Update]]></article-title>
<source><![CDATA[Can J Diabetes]]></source>
<year>2016</year>
<volume>40</volume>
<page-range>484-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Approaches to Glycemic Treatment]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2015</year>
<volume>38</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S41-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hernáez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes mellitus tipo 2 y enfermedad cardiovascular en España: una revisión descriptiva]]></article-title>
<source><![CDATA[Rev Esp Cardiol Supl]]></source>
<year>2008</year>
<volume>8</volume>
<numero>C</numero>
<issue>C</issue>
<page-range>53-61</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barreto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kislaya]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Gaio]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Namorado]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, awareness and control of diabetes in Portugal: results from the first National Health Examination Survey (INSEF 2015)]]></article-title>
<source><![CDATA[Diabetes Res Clin Pract]]></source>
<year>2018</year>
<volume>140</volume>
<page-range>271-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
